Half a century of experience in heterotaxy syndrome
Long-term outcomes at Mayo Clinic in the management of patients with heterotaxy syndrome.
Long-term outcomes at Mayo Clinic in the management of patients with heterotaxy syndrome.
This study compares the use and outcomes of heart transplants utilizing donation after circulatory death (DCD) versus donation after brain death (DBD) in the United States.
The COAPT study’s 5-year outcomes assess clinical parameters and mortality in patients with severe secondary mitral regurgitation (MR) after MitraClip implantation.
Comparative meta-analysis of prospective studies on urgent revascularization in patients with multivessel disease presenting specifically as Non-ST-Elevation Acute Coronary Syndrome (NSTE-ACS), via coronary artery bypass grafting or percutaneous intervention.
This study is a randomized, multicenter, prospective, open clinical trial comparing clinical outcomes 3 months after implanting an On-X mechanical mitral prosthesis in patients with standard anticoagulation ranges versus a lower target.
This is a multicenter, randomized clinical trial evaluating outcomes of transcatheter edge-to-edge tricuspid valve repair compared to optimized medical management in 350 patients with severe tricuspid regurgitation.
Analysis of post-procedure outcomes and mid-term follow-up of TAVI vs. SVA in a U.S. healthcare insurance database for patients with pure aortic insufficiency.
This meta-analysis, encompassing 6 clinical trials, compares percutaneous coronary intervention (PCI) and coronary artery bypass grafting (CABG) in cases of left main coronary artery disease or multivessel disease, presenting results stratified according to the SYNTAX score.
This review, published in JACC, addresses the global impact of infections in implanted cardiac electronic devices (CIEDs), providing treatment recommendations and potential improvements in application.
First multicenter randomized clinical trial assessing the outcomes of immediate VA-ECMO implantation compared to an initially conservative strategy (allowing subsequent VA-ECMO if hemodynamic deterioration occurs) in patients with severe or rapidly deteriorating cardiogenic shock.